Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (0)
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Thomas J Hwang, M.D.
Concepts (215)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Administration, Intravesical
Adolescent
Adult
Age Factors
Aged
Algorithms
Ambulatory Care
Analgesics, Opioid
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antineoplastic Agents
Antitubercular Agents
Area Under Curve
Artificial Intelligence
Bacterial Infections
BCG Vaccine
Biological Factors
Biological Products
Biomedical Research
California
Canada
Capital Financing
Cardiovascular Agents
Cardiovascular Diseases
Central Nervous System Agents
Central Nervous System Diseases
Child
Child, Preschool
Clinical Trials as Topic
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Clofazimine
Cohort Studies
Commerce
Communicable Diseases
Compassionate Use Trials
Computer Graphics
Conjunctivitis, Bacterial
Consumer Product Safety
Contact Tracing
Coronavirus Infections
Cost Sharing
Cost-Benefit Analysis
Costs and Cost Analysis
Cross-Sectional Studies
Cultural Diversity
Cycloserine
Databases, Factual
Decision Making
Decision Support Systems, Clinical
Developing Countries
Device Approval
Diabetes Mellitus, Type 2
Diffusion of Innovation
Disease-Free Survival
Drug and Narcotic Control
Drug Approval
Drug Costs
Drug Discovery
Drug Evaluation
Drug Industry
Drug Information Services
Drug Labeling
Drug Prescriptions
Drug Resistance, Bacterial
Drug Resistance, Multiple, Bacterial
Drug Utilization
Drugs, Essential
Drugs, Generic
Drugs, Investigational
Early Termination of Clinical Trials
Encyclopedias as Topic
Endpoint Determination
England
Equipment and Supplies
Equipment Safety
Escherichia coli
Escherichia coli Infections
Europe
European Union
Extensively Drug-Resistant Tuberculosis
Federal Government
Female
Financing, Government
Fluoroquinolones
Follow-Up Studies
France
Genome, Human
Genomics
Germany
Government Agencies
Government Regulation
Guidelines as Topic
Health Care Costs
Health Care Reform
Health Expenditures
Health Planning Technical Assistance
Health Policy
Health Services Accessibility
Humans
Hypoglycemic Agents
Immunotherapy
Infant
Infant, Newborn
Inflation, Economic
Information Dissemination
Information Seeking Behavior
Inpatients
Insurance Coverage
Insurance, Pharmaceutical Services
Internet
Investments
Isoxazoles
Japan
Legislation, Drug
Lenses, Intraocular
Leprostatic Agents
Macular Degeneration
Male
Marketing
Medicaid
Medical Device Recalls
Medical Oncology
Medicare
Medicare Part B
Medicare Part D
Medicine
Mental Disorders
Microbial Sensitivity Tests
Middle Aged
Migraine Disorders
Models, Economic
Molecular Targeted Therapy
Motivation
National Health Programs
Needs Assessment
Neglected Diseases
Negotiating
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Neoplasms
New York
Ophthalmic Solutions
Ophthalmology
Opioid-Related Disorders
Orphan Drug Production
Outpatients
Oxazolidinones
Pain
Pandemics
Patents as Topic
Patient Participation
Patient Selection
Patient-Centered Care
Pediatrics
Periodicals as Topic
Pharmaceutical Preparations
Pharmacology, Clinical
Pneumonia, Viral
Policy
Policy Making
Politics
Practice Guidelines as Topic
Prescription Drugs
Prescription Fees
Prescriptions
Product Surveillance, Postmarketing
Program Development
Proportional Hazards Models
Prostheses and Implants
Public Opinion
Public Policy
Public-Private Sector Partnerships
Publishing
Quality Improvement
Quality of Life
Randomized Controlled Trials as Topic
Rare Diseases
Regression Analysis
Reimbursement Mechanisms
Reimbursement, Incentive
Research Design
Retinal Diseases
Retrospective Studies
Safety
Small Business
Small Molecule Libraries
Software
State Health Plans
Statistics, Nonparametric
Surgical Equipment
Switzerland
Systems Analysis
Technology Assessment, Biomedical
Television
Therapies, Investigational
Time Factors
Treatment Failure
Treatment Outcome
Tropical Medicine
Tuberculosis
Tuberculosis, Multidrug-Resistant
United States
United States Department of Veterans Affairs
United States Food and Drug Administration
United States Government Agencies
Urinary Bladder Neoplasms
Urinary Tract Infections
Urologic Neoplasms
Vaccines
Visual Prosthesis
World Health Organization
Young Adult
Hwang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (215)
Derived automatically from this person's publications.
Device Approval
Prescription Drugs
United States Food and Drug Administration
Drug Costs
Drug Approval
Explore
_
Co-Authors (24)
People in Profiles who have published with this person.
Bourgeois, Florence
Preston, Mark
Ciolino, Joseph
Keshavjee, Salmaan
Rome, Benjamin
Explore
_
Similar People (60)
People who share similar concepts with this person.
Naci, Huseyin
Bourgeois, Florence
Avorn, Jerome
Sarpatwari, Ameet
Rome, Benjamin
Explore
_
Same Department
People in same department with this person.
Irani, Jennifer
Khalil, Raouf
Lake, Isabel
Piechura, Laura
Sulciner, Megan
Explore
_